Oslo, Norway, August 14, 2009
Photocure ASA (Oslo Stock Exchange: PHO) today presents its results for the second quarter 2009. A presentation will take place today in Oslo, Norway, beginning at 11.30 am (CET) and webcast through the Company's website www.photocure.no.
The main items in the report are:
Highlights
- Sales revenues increased 27% to NOK 28.9 million (NOK 22.7 million)
- Operating profit improved by NOK 3.2 million to NOK -14.5 million (NOK -17.7 million)
- Liquid funds amounted to NOK 150.6 million at the end of the period.
- Submitted NDA for Hexvix® in the USA.
President and CEO of Photocure, Kjetil Hestdal MD, PhD, says in a comment to the results, "We are pleased to present another quarter with strong growth in sales. The improved market position for our products are, among others, demonstrated by the fact that Hexvix is now used in half of all bladder cancer operations in Denmark.
The submission of the NDA for Hexvix in the USA represents a major step towards approval and commercialisation of Hexvix in the USA."
Photocure ASA is a Norwegian pharmaceutical company founded in 1993 and listed on Oslo Stock Exchange. The company develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technologies, targeting key dermatology and oncology markets.
Photocure has two products with sales and marketing approvals: Metvix®, which is a product developed for the treatment of skin cancer (basal cell carcinoma) and pre-cancerous skin lesions (actinic keratosis), and Hexvix®, which is developed for the detection of bladder cancer. Both products are based on the same photodynamic technology, combining the drug known as a photosensitiser with a light source that activates the photosensitiser. Photocure aims to develop a pipeline of follow-on products and technologies.
For further information, contact:
Photocure ASA
Attn. Kjetil Hestdal (President and CEO) or Christian Fekete (CFO)
Hoffsveien 48
NO-0377 Oslo, Norway
www.photocure.com
E-mail: kh@photocure.no or cf@photocure.no
www.photocure.com
E-mail: kh@photocure.no or cf@photocure.no
Telephone: +47 22 06 22 10
Kjetil Hestdal mobile +47 913 19 535 - Christian Fekete mobile +47 916 42 938
Kjetil Hestdal mobile +47 913 19 535 - Christian Fekete mobile +47 916 42 938
